“Central Repository System with Customizable Subset Schema Design and Simplification Layer” in Patent Application Approval Process (USPTO 20230109718): Allstate Insurance Company ...
The FDA will review an application to consider potential approval of Nubeqa plus androgen deprivation therapy for metastatic hormone-sensitive prostate cancer. The Food and Drug Administration (FDA) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback